From January 1, 2022 to March 23, 2022, the company has repurchased 240,000 shares, representing 0.84% for ¥255.53 million. With this, the company has completed the repurchase of 300,000 shares, representing 1.06% for ¥316.48 million under the buyback announced on July 12, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,336 JPY | -0.97% | -0.93% | +30.94% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.94% | 425M | |
+42.24% | 739B | |
+32.80% | 598B | |
-5.15% | 353B | |
+18.02% | 318B | |
+5.08% | 285B | |
+16.55% | 240B | |
+9.53% | 210B | |
-5.36% | 206B | |
+7.83% | 164B |
- Stock Market
- Equities
- 4886 Stock
- News ASKA Pharmaceutical Holdings Co.,Ltd.
- Tranche Update on ASKA Pharmaceutical Holdings Co.,Ltd.'s Equity Buyback Plan announced on July 12, 2021.